Cytology
9
1
1
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
11.1%
1 terminated out of 9 trials
50.0%
-36.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Application of EndoScell Intraoperative Cellular Probing Technology for Early-Stage Breast Cancer
18F-FDG PET/TC in TIR3A E TIR3B
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
Cervical Cytology DNA Methylation for Cervical Cancer Screening
Early Detection of Esophageal Cancer
UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
Immunohistochemical Staining of p16 for the Screening of Cervical Cancer
DNA Methylation Testing for the Screening of Uterine Cervical Lesion
Antibiotic, Gingival-biopsy, and Oral-smear Samples.